BioCentury
ARTICLE | Company News

Dura, Bristol-Myers sales and marketing update

January 4, 1999 8:00 AM UTC

DURA will exclusively distribute in the U.S. BMS's Maxipime cefepime and Azactam aztreonam antibiotics. BMS will receive an initial payment of $60 million, another payment of $70 million in 2003 and...